Why one trial participant's healthy birth after her CAR-T treatment for lupus is catching resesarchers' attention: ...
- Secures $3.2m in PIPE Financing - - $50m Term Sheet Obtained for Available Financing under Equity Line of Credit - ...
Nicky, who goes by @nickyshairandbeauty on TikTok, is on a mission to raise awareness for the symptoms she thought were ...
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis ...
Initial trials using CAR T cells in patients with autoimmune disorders have shown encouraging results ... and innate immune cells - Applications to a growing list of autoimmune conditions and cancer ...
a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ... and technological changes.
First and only NMPA-approved treatment for patients with CIDP in China Second VYVGART Hytrulo indication approved in China November 11, 2024 – ...
[12] Autoimmune hepatitis type 3 [13,14 ... and piecemeal necrosis. With advancing disease, bridging necrosis, panlobular necrosis, and multilobular necrosis may occur and ultimately lead to ...
Read about breakthroughs to treat lupus, a possible birth-control revolution, a food-allergy fix that’s been hiding in plain ...
Honored as Startup Technology Company of the Year, Claimable uses AI to help patients generate insurance appeals that the ...
As drugmakers take lessons from oncology in developing CAR T cells for other diseases, they must contend with risks that ...
UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...